# Transforming cisplatin into targeted photothermal chemotherapeutics through the platinum-phosphate coordination within a hyaluronan nanogel

**Authors:** Yiyi Zhang, Huimin Wang, Hua Guo, Xiaorong Gou, Xinxin Hao, Jiayi Li, Hong Deng, Weiqi Zhang

PMC · DOI: 10.1126/sciadv.adz7615 · 2026-03-18

## TL;DR

This paper presents a new nanogel that turns cisplatin into a targeted and less toxic cancer treatment by combining chemotherapy with photothermal therapy.

## Contribution

A novel HA nanogel using platinum-phosphate coordination to enable targeted photothermal chemotherapy with cisplatin.

## Key findings

- The HA/PtP nanogel achieves 32.08% photothermal conversion efficiency.
- The nanogel releases cisplatin under acidic conditions through reversible Pt-phos interactions.
- It shows effective tumor targeting and reduced toxicity in mouse models.

## Abstract

Cisplatin’s (Cis’s) antitumor efficacy is limited by dose-dependent toxicity due to nonspecific tissue distribution. While targeted Cis delivery and combination therapies boost therapeutic efficacy, developing multifunctional yet simplified formulations remains challenging. Inspired by the Cis’s interaction with DNA, here, we transformed Cis into a reversible photothermal agent through the platinum-phosphate (Pt-phos) interaction within a hyaluronan (HA) nanogel (named as HA/PtP) to afford synergistic photothermal therapy (PTT) and chemotherapy. The HA/PtP nanogel exhibits near infrared absorption and 32.08% photothermal conversion efficiency, and degrades to release Cis through the reversible Pt-phos interaction under acidic conditions. Leveraging HA’s intrinsic CD44 targeting, HA/PtP nanogel simultaneously enables highly efficient PTT and targeted chemotherapy in 4T1 breast tumor xenografts. Moreover, HA/PtP-based PTT successfully mimics hyperthermic intraperitoneal chemotherapy (HIPEC) but with alleviated Cis toxicity in MC38 metastatic mouse model. This HA/PtP nanogel represents a rationally designed Cis nanomedicine integrating the PTT with self-targeting and facile preparation.

The platinum-phosphate coordination within HA nanogel converts cisplatin into a targeted anticancer photothermal chemotherapeutic.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033), doxorubicin (PubChem CID 31703)
- **Diseases:** breast cancer (MONDO:0004989)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, alp (alopecia, recessive) [NCBI Gene 11691], H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}
- **Diseases:** weight loss (MESH:D015431), Tumor (MESH:D009369), kidney and liver dysfunction (MESH:D051437), inflammation (MESH:D007249), breast cancer (MESH:D001943), hyperthermia (MESH:D005334), metastases (MESH:D009362), colorectal peritoneal metastasis (MESH:D010538), death (MESH:D003643), kidney damage (MESH:D007674), vascular harm (MESH:D057772), colon cancer (MESH:D015179), Cytotoxicity (MESH:D064420), HIPEC (MESH:D000084202)
- **Chemicals:** calcein-AM (MESH:C085925), dimethyl sulfoxide (MESH:D004121), N-hydroxysuccinimide (MESH:C001426), bilirubin (MESH:D001663), H&amp;E (MESH:D006371), penicillin (MESH:D010406), OH- (MESH:C031356), PB (MESH:D007854), L (MESH:D007930), P5 (MESH:C016883), H3O (MESH:C027727), phosphate (MESH:D010710), CREA (MESH:D003404), MnO2 (MESH:C016552), water (MESH:D014867), P (MESH:D010758), NaCl (MESH:D012965), N (MESH:D009584), copper (MESH:D003300), Hoechst 33342 (MESH:C017807), glutaraldehyde (MESH:D005976), phytic acid (MESH:D010833), graphene (MESH:D006108), CO2 (MESH:D002245), Tween 20 (MESH:D011136), hematoxylin (MESH:D006416), Triton X-100 (MESH:D017830), O. (MESH:D010100), O-phenylenediamine (MESH:C034193), streptomycin (MESH:D013307), H (MESH:D006859), NB (MESH:C008619), DMF (MESH:D004126), EDC (-), polymers (MESH:D011108), Cy5 (MESH:C085321), HA (MESH:D006820), Cis (MESH:D002945), uranyl acetate (MESH:C005460), Au (MESH:D006046), 4',6-diamidino-2-phenylindole (MESH:C007293), eosin (MESH:D004801), urea nitrogen (MESH:C530477), propidium iodide (MESH:D011419), Disodium hydrogen phosphate (MESH:C018279), paraformaldehyde (MESH:C003043), Pt (MESH:D010984)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Balb — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0637), S21 — Mus musculus (Mouse), Transformed cell line (CVCL_K245), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), MC38 — Mus musculus (Mouse), Mouse colon adenocarcinoma, Cancer cell line (CVCL_B288), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), mHIPEC — Spodoptera frugiperda (Fall armyworm), Spontaneously immortalized cell line (CVCL_Z366), Balb/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12998518/full.md

---
Source: https://tomesphere.com/paper/PMC12998518